After Hours Summary: RNDY +12.7%, PEIX +11.6%, BIOL +10.3%, ECR -16.6%, PCOM -9.8%, ALSK -5.3% following earnings/guidance
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings: RNDY +12.7%, PEIX +11.6%, BIOL +10.3%, HRTG +7.8%, MLR +6.9%, VSLR +5.5%, DAR +4.4%, SQNM +1.4%, TSE +1.3%, AXAS +1.2%, ALDW +0.6%, POWR +0.3%
Companies trading higher in after hours in reaction to news: CPRX +5.3% (Amifampridine phosphate for the treatment of congenital myasthenic syndromes granted FDA Orphan Designation status), GLDD +4.7% (awarded ~$134.5 mln Army contract), TGTX +4.2% (discloses terms of Global Collaboration with Checkpoint Therapeutics; to make an up-front payment of $500k), PCYC +3.1% (seeing reports that co has agreed to be acquired by Johnson & Johnson)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: ECR -16.6%, PCOM -9.8%, ALSK -5.3%, SMTC -5.3%, CCRN -4%, HRB -3.1%, ERJ -2.6%, CPE -1.3%, MOMO -0.8%, PPO -0.6%
Companies trading lower in after hours in reaction to news: VNDA -7.3% (announced tradipitant Phase 2 proof of concept study results for chronic pruritus in atopic dermatitis: no significant differences seen between treatment groups due to high placebo effect), ECA -3.8% (announced agreement with underwriters syndicate for bought deal purchase of ~85.62 mln common shares of its common stock for C$14.60/share; ~C$1.25 billion in gross proceeds expected), ARI -2.9% (announced public offering of 10 mln shares of common stock), NSR -2.7% (released a statement on the LNPA vendor selection; said the process has "been botched procedurally"), LF -1.5% (disclosed that on February 27, 2015, Sarah A. Mason, Corporate Controller and Principal Accounting Officer notified the Company that she is resigning from the Company, effective March 20, 2015)